Pathogenesis and management of recurrent urinary tract infection in women

Current Opinion in Urology

Volumn 10, Issue 1, 2000, Pages 29-33

  Madersbacher, Stephan ^a   Thalhammer, Florian ^b   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; BLOOD GROUP ANTIGEN; CONTRACEPTIVE AGENT; ESTRIOL; ESTROGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPERMICIDAL AGENT; TRIMETHOPRIM;

ACUPUNCTURE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BEHAVIOR THERAPY; CONDOM; CYSTITIS; ESCHERICHIA COLI; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FRUIT JUICE; GENETIC SUSCEPTIBILITY; HOST SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNE STATUS; PATHOGENESIS; PERSONAL HYGIENE; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; RISK FACTOR; SELF CARE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SIDE EFFECT; URINARY TRACT INFECTION; VAGINA DISEASE; VAGINA FLORA; VAGINA RING; VAGINA SECRETION;

ACUPUNCTURE THERAPY; ADULT; ANTI-BACTERIAL AGENTS; COMPLEMENTARY THERAPIES; CONTRACEPTIVE AGENTS, FEMALE; ESCHERICHIA COLI INFECTIONS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; RECURRENCE; RISK ASSESSMENT; URINARY TRACT INFECTIONS; VAGINA; WOMEN'S HEALTH;

EID: 0033969717     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200001000-00008     Document Type: Review

References (22)

1. 1 Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329:1328-1334.
2. 2 Stapleton A. Prevention of recurrent urinary-tract infections in women. Lancet 1999; 353:7-8 This is an excellent review of the pathogenesis and therapy of recurrent UTI in women.
3. 3 Stapleton AE, Stroud MR, Hakomori SI, Stamm WE. The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins. Infect Immun 1998; 66:3856-3861.
4. 4 Hopkins WJ, Heisey DM, Lorentzen DF, Uehling DT. A comparative study of major histcompatibility complex and red blood cell antigen phenotypes as risk factors for recurrent urinary tract infections in women. J Infect Dis 1998; 177:1296-1301.
5. 5 Hopkins WJ, Heisey DM, Uehling DT. Association of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection. Vaccine 1999; 17:169-171. The efficacy of a vaginal mucosal UTI vaccine may be influenced by an individual's HLA-DR phenotype.
6. 2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998; 178:446-450.
7. 7 Hooton TM, Hillier S, Johnson C, Roberts PL, Stamm WE. Escherichia coli bacteriuria and contraceptive method. JAMA 1991; 265:64-69.
8. 8 Fihn SD, Boyko EJ, Chen CL, Normand EH, Yarbro P, Scholes D. Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Arch Intern Med 1998; 158:281-287.
9. 9 Bengtsson C, Bengtsson U, Bjorkelund C, Lincoln K, Sigurdsson JA. Bacteriuria in a population sample of women: 24-year follow-up study. Results from the prospective population-based study of women in Gothenburg, Sweden. Scand J Urol Nephrol 1998; 32:284-289.
10. 10 Engel JD, Schaeffer AJ. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am 1998; 25:685-701. This review discusses the cause and pathophysiology behind recurrent UTIs in women.
11. 11 Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother 1998; 42:363-371.
12. 12 Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999; 161:207-211. Intermittent self-start therapy is effective, safe and economical in women with recurrent UTI.
13. 13 Krieger JN. Editorial comment. J Urol 1999; 161:211.
14. 14 Raz R, Stamm WE. A controlled trial of intravaginal estrogen in postmenopausal women with recurrent urinary tract infection. N Engl J Med 1993; 329:753-756.
15. 15 Lobel B. Therapeutic strategies in urinary tract infections in women. Ann Urol (Paris) 1998; 32:353-358.
16. 16 Cardozo L, Bennes C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 1998; 105:403-407.
17. 17 Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180:1072-1079. An oestradiol-releasing silicone vaginal ring is useful to prolong the time to next recurrence among postmenopausal women with recurrent UTI.
18. 18 Tchoudomirova K, Mardh PA, Kallings I, Nilsson S, Hellberg D. History, clinical findings, sexual behavior and hygiene habits in women with and without recurrent episodes of urinary symptoms. Acta Obstet Gynecol Scand 1998; 77:654-659. This study demonstrates that sexual behaviour and genital hygiene habits play an aetiological role in the lives of women with recurrent episodes of urinary symptoms.
19. 19 Aune A, Alraek T, LiHua H, Baerheim A. Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 1998; 16:37-39.
20. 20 Kerr KG. Cranberry juice and prevention of recurrent urinary tract infection (letter). Lancet 1999; 353:673-.
21. 21 Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Ag Chemother 1989; 33:92-98.
22. 22 Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 324:751-754.